CSF1R and Alzheimer disease: Pharmacological inhibition of CSF1R with http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5685 reduces microglial proliferation and prevents disease progression in a mouse model of AD, but this does not correlate with amyloid‐β plaque numbers [http://www.ncbi.nlm.nih.gov/pubmed/26747862?dopt=AbstractPlus].